Pluri (PLUR) Other Non-Current Assets (2011 - 2025)
Pluri (PLUR) reported Other Non-Current Assets of $310000.0 for Q4 2025, down 41.18% year-over-year from $527000.0 in Q4 2024, and down 65.9% quarter-over-quarter from $909000.0 in Q3 2025.
Pluri (PLUR) Other Non-Current Assets (2011 - 2025) Analysis & Trends
Pluri (PLUR) has 15 years of Other Non-Current Assets data on file, last reported at $310000.0 in Q4 2025.
- Other Non-Current Assets for Q4 2025 came in at $310000.0, down 41.18% year-over-year; the trailing twelve-month figure through Dec 2025 was $310000.0 (down 41.18% YoY), and the FY2025 annual result was $879000.0, up 38.64% from the prior year.
- Other Non-Current Assets retreated to $310000.0 in Q4 2025 per PLUR's latest filing, from $909000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $1.0 million in Q4 2023 and troughed at $5000.0 in Q3 2022.
- A 5-year average of $550550.0 and a median of $635500.0 in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2021 and 2022: Other Non-Current Assets surged 13800.0% in 2021, then slumped 99.27% in 2022.
- A 5-year view of Other Non-Current Assets shows it stood at $18000.0 in 2021, then soared by 3216.67% to $597000.0 in 2022, then soared by 70.52% to $1.0 million in 2023, then slumped by 48.23% to $527000.0 in 2024, then plunged by 41.18% to $310000.0 in 2025.
- Business Quant data shows PLUR's Other Non-Current Assets at $310000.0 in Q4 2025, $909000.0 in Q3 2025, and $879000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Pluri | 21.85 Mn | 22.34 Mn | 86,000.00 | 310,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 310,000.00 |
| Sep 30, 2025 | 909,000.00 |
| Jun 30, 2025 | 879,000.00 |
| Mar 31, 2025 | 786,000.00 |
| Dec 31, 2024 | 527,000.00 |
| Sep 30, 2024 | 653,000.00 |
| Jun 30, 2024 | 634,000.00 |
| Mar 31, 2024 | 637,000.00 |
| Dec 31, 2023 | 1.02 Mn |
| Sep 30, 2023 | 611,000.00 |
| Jun 30, 2023 | 439,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Dec 31, 2022 | 597,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 661,000.00 |
| Mar 31, 2022 | 669,000.00 |
| Dec 31, 2021 | 18,000.00 |
| Sep 30, 2021 | 683,000.00 |
| Jun 30, 2021 | 7,000.00 |
| Mar 31, 2021 | 695,000.00 |